These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
480 related articles for article (PubMed ID: 22212295)
1. Botulinum toxin A modulates afferent fibers in neurogenic detrusor overactivity. Conte A; Giannantoni A; Proietti S; Giovannozzi S; Fabbrini G; Rossi A; Porena M; Berardelli A Eur J Neurol; 2012 May; 19(5):725-32. PubMed ID: 22212295 [TBL] [Abstract][Full Text] [Related]
2. Intradetrusorial Botulinum Toxin in Patients with Multiple Sclerosis: A Neurophysiological Study. Conte A; Giannantoni A; Gubbiotti M; Pontecorvo S; Millefiorini E; Francia A; Porena M; Berardelli A Toxins (Basel); 2015 Aug; 7(9):3424-35. PubMed ID: 26343721 [TBL] [Abstract][Full Text] [Related]
3. Injections of Botulinum Toxin A into the detrusor to treat neurogenic detrusor overactivity secondary to spinal cord injury. Chen G; Liao L Int Urol Nephrol; 2011 Sep; 43(3):655-62. PubMed ID: 21110094 [TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy. Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of detrusor botulinum toxin A injection on neurogenic detrusor overactivity in patients with different levels of spinal cord injury and types of detrusor sphincter dyssynergia. Chen CY; Liao CH; Kuo HC Spinal Cord; 2011 May; 49(5):659-64. PubMed ID: 21243000 [TBL] [Abstract][Full Text] [Related]
6. Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder. Chen SF; Chang CH; Kuo HC Toxins (Basel); 2016 May; 8(6):. PubMed ID: 27249005 [TBL] [Abstract][Full Text] [Related]
8. More Than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to Be Learned. Leitner L; Guggenbühl-Roy S; Knüpfer SC; Walter M; Schneider MP; Tornic J; Sammer U; Mehnert U; Kessler TM Eur Urol; 2016 Sep; 70(3):522-8. PubMed ID: 27106070 [TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A in patients with Parkinson's disease and refractory overactive bladder. Giannantoni A; Conte A; Proietti S; Giovannozzi S; Rossi A; Fabbrini G; Porena M; Berardelli A J Urol; 2011 Sep; 186(3):960-4. PubMed ID: 21791351 [TBL] [Abstract][Full Text] [Related]
10. Re: botulinum toxin A modulates afferent fibers in neurogenic detrusor overactivity. Wein AJ J Urol; 2014 May; 191(5):1340-1. PubMed ID: 24745503 [No Abstract] [Full Text] [Related]
11. Botulinum toxin A in the treatment of spinal cord injury patients with refractory neurogenic detrusor overactivity. Alvares RA; Silva JA; Barboza AL; Monteiro RT Int Braz J Urol; 2010; 36(6):732-7. PubMed ID: 21176280 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic outcome and patient adherence to repeated onabotulinumtoxinA detrusor injections in chronic spinal cord-injured patients and neurogenic detrusor overactivity. Chen SF; Kuo HC J Formos Med Assoc; 2015 Jul; 114(7):583-9. PubMed ID: 24262922 [TBL] [Abstract][Full Text] [Related]
13. Central inhibitory effect of intravesically applied botulinum toxin A in chronic spinal cord injury. Munoz A; Somogyi GT; Boone TB; Smith CP Neurourol Urodyn; 2011 Sep; 30(7):1376-81. PubMed ID: 21509809 [TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of botulinum toxin A detrusor injections in the treatment of neurogenic detrusor overactivity after spinal cord injury. Mehta S; Hill D; McIntyre A; Foley N; Hsieh J; Ethans K; Teasell RW; Loh E; Welk B; Wolfe D Arch Phys Med Rehabil; 2013 Aug; 94(8):1473-81. PubMed ID: 23632286 [TBL] [Abstract][Full Text] [Related]
15. Factors that influence the urodynamic results of botulinum toxin in the treatment of neurogenic hyperactivity. Gutiérrez-Martín P; Vírseda-Chamorro M; Salinas Casado J; Gómez-Rodríguez A; Esteban-Fuertes M Actas Urol Esp; 2015 May; 39(4):217-21. PubMed ID: 25582926 [TBL] [Abstract][Full Text] [Related]
16. The Botulinum Treatment of Neurogenic Detrusor Overactivity: The Double-Face of the Neurotoxin. Traini C; Vannucchi MG Toxins (Basel); 2019 Oct; 11(11):. PubMed ID: 31652991 [TBL] [Abstract][Full Text] [Related]
17. Effect of intravesical botulinum neurotoxin-A injection on detrusor hyperreflexia in spinal cord injured patients. Ge XT; Li YF; Wang Q; Zhao JN Drug Res (Stuttg); 2015 Jun; 65(6):327-31. PubMed ID: 25350080 [TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin type A for refractory neurogenic detrusor overactivity in spinal cord injured patients in Singapore. Tow AM; Toh KL; Chan SP; Consigliere D Ann Acad Med Singap; 2007 Jan; 36(1):11-7. PubMed ID: 17285181 [TBL] [Abstract][Full Text] [Related]
19. Impairment of sensory afferents by intrathecal administration of botulinum toxin A improves neurogenic detrusor overactivity in chronic spinal cord injured rats. Coelho A; Oliveira R; Cruz F; Cruz CD Exp Neurol; 2016 Nov; 285(Pt B):159-166. PubMed ID: 27235935 [TBL] [Abstract][Full Text] [Related]
20. Preclinical assessment of potential interactions between botulinum toxin and neuromodulation for bladder micturition reflex. Su X; Nickles A; Nelson DE BMC Urol; 2015 Jun; 15():50. PubMed ID: 26055982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]